Envoy Medical (COCH) Non Operating Investment Income (2021)

Envoy Medical (COCH) reported Non Operating Investment Income of -$512000.0 for Q1 2021.

Envoy Medical (COCH) Non Operating Investment Income (2021) Analysis & Trends

Envoy Medical (COCH) has 1 years of Non Operating Investment Income data on file, last reported at -$512000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Abbott Laboratories 182.36 Bn 175.06 Bn 6.27 Bn -
2 Stryker 128.86 Bn 125.99 Bn 3.81 Bn -
3 Medtronic 108.02 Bn 98.80 Bn 6.41 Bn -
4 Boston Scientific 68.21 Bn 66.76 Bn 3.61 Bn -
5 Edwards Lifesciences 48.19 Bn 44.52 Bn 1.29 Bn -
6 Dexcom 28.30 Bn 27.18 Bn 750.30 Mn -
7 GE HealthCare Technologies 28.02 Bn 25.74 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 24.11 Bn 20.99 Bn 2.07 Bn -
10 Envoy Medical 47.30 Mn 22.05 Mn -274,000.00 -

Historic Data

Download Data
DateValue
Mar 31, 2021 -512,000.00
Mar 31, 2021 -512,000.00